A PHASE I STUDY OF CONTINUOUS AMBULATORY INTRAVENOUS INFUSION OF DOCETAXEL IN WO

多西紫杉醇连续门诊静脉输注的I期研究

• 批准号: 7375920
• 负责人: LEVI S. DOWNS
• 金额: $ 1.18万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375920
• 关键词: PHASE; STUDY; CONTINUOUS; AMBULATORY; INTRAVENOUS

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Phase I study of continuous ambulatory intravenous infusion of docetaxel in women with progressive or recurrent gynecologic cancer. Patients will receive docetaxel through an I-Flow pump connected to an existing intravenous line of the physician's choosing. Docetaxel will be adminstered via the pump continuously for a maximum of 180 days. Patients will be closely monitored throughout treatment by blood counts and assessment of adverse reactions.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。对患有进行性或复发性妇科癌症的女性进行连续门诊静脉输注多西紫杉醇的 I 期研究。患者将通过连接到医生选择的现有静脉管线的 I-Flow 泵接受多西紫杉醇。多西紫杉醇将通过泵连续给药最多 180 天。在整个治疗过程中，将通过血细胞计数和不良反应评估来密切监测患者。